Artemisinin & Leukemia

Artemisinin and its derivatives: a potential treatment for leukemia
https://pubmed.ncbi.nlm.nih.gov/30540593/

Evaluation of artemisinins for the treatment of acute myeloid leukemia
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918815/

Dihydroartemisinin Inhibits the Proliferation of Leukemia Cells K562 by Suppressing PKM2 and GLUT1 Mediated Aerobic Glycolysis
https://pubmed.ncbi.nlm.nih.gov/32546972/

Antileukemic efficacy of a potent artemisinin combined with sorafenib and venetoclax
https://pubmed.ncbi.nlm.nih.gov/33560385/

Repurposing of artemisinin-type drugs for the treatment of acute leukemia
https://pubmed.ncbi.nlm.nih.gov/32485311/

Antitumor Research on Artemisinin and Its Bioactive Derivatives
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6102173/

Artemisinin-derived dimer ART-838 potently inhibited human acute leukemias, persisted in vivo, and synergized with antileukemic drugs
https://pubmed.ncbi.nlm.nih.gov/26771236/